Association between genetic polymorphisms in the renin-angiotensin system and systolic heart failure revised by a propensity score-based analysis

Cardiology

Volumn 116, Issue 4, 2010, Pages 279-285

  Chang, Sheng Nan ^a   Lin, Jou Wie ^a   Juang, Jyh Ming ^a   Tsai, Chai Ti ^a   Hwang, Juey Jen ^a   Chiang, Fu Tien ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Congestive heart failure; Genetics; Renin angiotensin system

Indexed keywords

ANGIOTENSINOGEN; DIPEPTIDYL CARBOXYPEPTIDASE;

ADULT; ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; DNA SEQUENCE; FEMALE; GENETIC ASSOCIATION; GENOTYPE; HEART FAILURE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SCORING SYSTEM;

CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; CORONARY ANGIOGRAPHY; ECHOCARDIOGRAPHY; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HEART FAILURE, SYSTOLIC; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; PROPENSITY SCORE; RENIN-ANGIOTENSIN SYSTEM; RISK FACTORS;

EID: 77956828582     PISSN: 00086312     EISSN: None     Source Type: Journal    
DOI: 10.1159/000321123     Document Type: Article

References (31)

1. Greenberg B: An ACE in the hole alternative pathways of the renin-angiotensin system and their potential role in cardiac remodeling. J Am Coll Cardiol 2008; 52: 755-757.
2. Braunwald E, Domanski MJ, Fowler SE, Geller NL, Gersh BJ, Hsia J, Pfeffer MA, Rice MM, Rosenberg YD, Rouleau JL: Angiotensin- converting enzyme inhibition in stable coronary artery disease. N Engl J Med 2004; 351: 2058-2068.
3. Lim HS, MacFadyen RJ, Lip GY: Diabetes mellitus, the renin-angiotensin- aldosterone system, and the heart. Arch Intern Med 2004; 164: 1737-1748.
4. Pilbrow AP, Palmer BR, Frampton CM, Yandle TG, Troughton RW, Campbell E, Skelton L, Lainchbury JG, Richards AM, Cameron VA: Angiotensinogen M235T and T174M gene polymorphisms in combination doubles the risk of mortality in heart failure. Hypertension 2007; 49: 322-327.
5. Patel DA, Li S, Chen W, Srinivasan SR, Boerwinkle E, Berenson GS: G-6A polymorphism of the angiotensinogen gene and its association with left ventricular mass in asymptomatic young adults from a biethnic community: the Bogalusa Heart Study. Am J Hypertens 2005; 18: 1437-1441.
6. Sato N, Katsuya T, Nakagawa T, Ishikawa K, Fu Y, Asai T, Fukuda M, Suzuki F, Nakamura Y, Higaki J, Ogihara T: Nine polymorphisms of angiotensinogen gene in the susceptibility to essential hypertension. Life Sci 2000; 68: 259-272.
7. Danser AH, Schalekamp MA, Bax WA, van den Brink AM, Saxena PR, Riegger GA, Schunkert H: Angiotensin-converting enzyme in the human heart. Effect of the deletion/ insertion polymorphism. Circulation 1995; 92: 1387-1388.
8. McNamara DM, Holubkov R, Postava L, Janosko K, MacGowan GA, Mathier M, Murali S, Feldman AM, London B: Pharmacogenetic interactions between angiotensin-converting enzyme inhibitor therapy and the angiotensin-converting enzyme deletion polymorphism in patients with congestive heart failure. J Am Coll Cardiol 2004; 44: 2019-2026.
9. Wang Y, Ng MC, So WY, Tong PC, Ma RC, Chow CC, Cockram CS, Chan JC: Prognostic effect of insertion/deletion polymorphism of the ACE gene on renal and cardiovascular clinical outcomes in Chinese patients with type 2 diabetes. Diabetes Care 2005; 28: 348-354.
10. Henry WL, DeMaria A, Gramiak R, King DL, Kisslo JA, Popp RL, Sahn DJ, Schiller NB, Tajik A, Teichholz LE, Weyman AE: Report of the American Society of Echocardiography Committee on Nomenclature and Standards in Two-Dimensional Echocardiography. Circulation 1980; 62: 212-217. (Pubitemid 10035638)
11. Sturmer T, Joshi M, Glynn RJ, Avorn J, Rothman KJ, Schneeweiss S: A review of the application of propensity score methods yielded increasing use, advantages in specific settings, but not substantially different estimates compared with conventional multivariable methods. J Clin Epidemiol 2006; 59: 437-447.
12. Chiang FT, Hsu KL, Tseng CD, Hsiao WH, Lo HM, Chern TH, Tseng YZ: Molecular variant M235T of the angiotensinogen gene is associated with essential hypertension in Taiwanese. J Hypertens 1997; 15: 607-611.
13. Zimmermann J, Voss H, Schwager C, Stegemann J, Ansorge W: Automated Sanger dideoxy sequencing reaction protocol. FEBS Lett 1988; 233: 432-436.
14. Rigat B, Hubert C, Corvol P, Soubrier F: PCR detection of the insertion/deletion polymorphism of the human angiotensin-converting enzyme gene (DCP1) (dipeptidyl carboxypeptidase 1). Nucleic Acids Res 1992; 20: 1433.
15. Sethi AA, Nordestgaard BG, Gronholdt ML, Steffensen R, Jensen G, Tybjærg-Hansen A: Angiotensinogen single nucleotide polymorphisms, elevated blood pressure, and risk of cardiovascular disease. Hypertension 2003; 41: 1202-1211.
16. Pereira TV, Nunes AC, Rudnicki M, Yamada Y, Pereira AC, Krieger JE: Meta-analysis of the association of four angiotensinogen polymorphisms with essential hypertension: a role beyond M235T? Hypertension 2008; 51: 778-783.
17. Zakrzewski-Jakubiak M, de Denus S, Dube MP, Belanger F, White M, Turgeon J: Ten renin- angiotensin system-related gene polymorphisms in maximally treated Canadian Caucasian patients with heart failure. Br J Clin Pharmacol 2008; 65: 742-751.
18. Liu Y, Jin W, Jiang ZW, Zhang KX, Sheng HH, Jin L, Sheng YY, Huang W, Yu JD: Relationship between six single nucleotide polymorphisms of angiotensinogen gene and essential hypertension (in Chinese). Zhonghua Yi Xue Yi Chuan Xue Za Zhi 2004; 21: 116-119.
19. Tsai CT, Lai LP, Lin JL, Chiang FT, Hwang JJ, Ritchie MD, Moore JH, Hsu KL, Tseng CD, Liau CS, Tseng YZ: Renin-angiotensin system gene polymorphisms and atrial fibrillation. Circulation 2004; 109: 1640-1646.
20. Tsai CT, Hwang JJ, Ritchie MD, Moore JH, Chiang FT, Lai LP, Hsu KL, Tseng CD, Lin JL, Tseng YZ: Renin-angiotensin system gene polymorphisms and coronary artery disease in a large angiographic cohort: detection of high order gene-gene interaction. Atherosclerosis 2007; 195: 172-180.
21. Schut AF, Bleumink GS, Stricker BH, Hofman A, Witteman JC, Pols HA, Deckers JW, Deinum J, van Duijn CM: Angiotensin-converting enzyme insertion/deletion polymorphism and the risk of heart failure in hypertensive subjects. Eur Heart J 2004; 25: 2143-2148.
22. Huang W, Xie C, Zhou H, Yang T, Sun M: Association of the angiotensin-converting enzyme gene polymorphism with chronic heart failure in Chinese Han patients. Eur J Heart Fail 2004; 6: 23-27.
23. Covolo L, Gelatti U, Metra M, Donato F, Nodari S, Pezzali N, Dei Cas L, Nardi G: Angiotensin-converting-enzyme gene polymorphism and heart failure: a case-control study. Biomarkers 2003; 8: 429-436.
24. Van Berlo JH, Pinto YM: Polymorphisms in the RAS and cardiac function. Int J Biochem Cell Biol 2003; 35: 932-943.
25. Huang WY, Sun M, Zhou HY, Pei ZF, Yang TL: Effect of the polymorphism of the angiotensin- converting enzyme gene on the drug treatment in patients with chronic heart failure (in Chinese). Zhong Nan Da Xue Xue Bao Yi Xue Ban 2004; 29: 686-689.
26. Sanderson JE, Young RP, Yu CM, Chan S, Critchley JA, Woo KS: Lack of association between insertion/deletion polymorphism of the angiotensin- converting enzyme gene and end-stage heart failure due to ischemic or idiopathic dilate cardiomyopathy in the Chinese. Am J Cardiol 1996; 77: 1008-1010.
27. Sanderson JE, Yu CM, Young RP, Shum IO, Wei S, Arumanayagam M, Woo KS: Influence of gene polymorphisms of the reninangiotensin system on clinical outcome in heart failure among the Chinese. Am Heart J 1999; 137: 653-657.
28. Andersson B, Sylven C: The DD genotype of the angiotensin-converting enzyme gene is associated with increased mortality in idiopathic heart failure. J Am Coll Cardiol 1996; 28: 162-167.
29. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F: An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990; 86: 1343-1346.
30. Cambien F, Costerousse O, Tiret L, Poirier O, Lecerf L, Gonzales MF, Evans A, Arveiler D, Cambou JP, Luc G, et al: Plasma level and gene polymorphism of angiotensin-converting enzyme in relation to myocardial infarction. Circulation 1994; 90: 669-676. (Pubitemid 24242731)
31. Tiret L, Rigat B, Visvikis S, Breda C, Corvol P, Cambien F, Soubrier F: Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels. Am J Hum Genet 1992; 51: 197-205.